Another fight over an $87 million mixed-use Canberra development may be on the cards, after the project’s liquidators won approval to assign potential claims against WSP and builder Construction Control over alleged stitch bolt defects.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
A judge has found that three directors at ASX-listed investment firm Keybridge Capital were validly removed and replaced at a meeting last month.
News Corp has agreed to removed posts that allegedly defamed a senior member of the Hells Angels bikie gang by labelling him a “cocaine kingpin” and “fugitive from justice”.
Former directors of collapsed Sydney developer Dyldam have been targeted by a liquidator over claims allegedly worth at least $33 million.
Fortrend Securities has appealed a finding that it breached the Fair Work Act in withholding the bonuses of two financial advisors who jumped to rival Shaw & Partners.
General Motors has defeated a class action by Australian car dealers over its decision to retire the Holden brand, with a judge finding the car maker did not breach its agreements.
A judge was too exacting in deciding the applicant in a shareholder class action against engineering services firm Worley suffered no loss from misleading guidance, an appeals court has heard.
An appeals court has found Zip Co infringed the ‘Zip’ trade mark of mortgage provider Firstmac, making orders restraining the buy now, pay later giant from using the name.